NO20020014L - Farmasöytisk sammensetning som inneholder fenofibrat og fremgangsmåte til fremstilling derav - Google Patents

Farmasöytisk sammensetning som inneholder fenofibrat og fremgangsmåte til fremstilling derav

Info

Publication number: NO20020014L
Authority: NO; Norway
Prior art keywords: pharmaceutical composition; surfactant; preparation; composition containing; cellulose derivative
Prior art date: 1999-07-09

Application number

NO20020014A

Other languages

English (en)

Other versions

NO333301B1 (no

NO20020014D0 (no

Inventor

Bruno Criere

Pascal Suplie

Philippe Chenevier

Original Assignee

Ethypharm Lab Prod Ethiques

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-09

Filing date

2002-01-02

Publication date

2002-03-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20020014(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-01-02 Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques

2002-01-02 Publication of NO20020014D0 publication Critical patent/NO20020014D0/no

2002-03-04 Publication of NO20020014L publication Critical patent/NO20020014L/no

2013-04-29 Publication of NO333301B1 publication Critical patent/NO333301B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biophysics (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO20020014A 1999-07-09 2002-01-02 Farmasoytisk sammensetning som inneholder fenofibrat og fremgangsmate til fremstilling derav NO333301B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9908923A FR2795961B1 (fr)	1999-07-09	1999-07-09	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
PCT/FR2000/001971 WO2001003693A1 (fr)	1999-07-09	2000-07-07	Composition pharmaceutique contenant du fenofibrate et procede de preparation

Publications (3)

Publication Number	Publication Date
NO20020014D0 NO20020014D0 (no)	2002-01-02
NO20020014L true NO20020014L (no)	2002-03-04
NO333301B1 NO333301B1 (no)	2013-04-29

Family

ID=9547923

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20020014A NO333301B1 (no)	1999-07-09	2002-01-02	Farmasoytisk sammensetning som inneholder fenofibrat og fremgangsmate til fremstilling derav

Country Status (37)

Country	Link
US (4)	US7101574B1 (no)
EP (3)	EP1523983B1 (no)
JP (2)	JP4841092B2 (no)
KR (3)	KR20020025188A (no)
CN (2)	CN1204885C (no)
AT (3)	ATE291912T1 (no)
AU (1)	AU782282B2 (no)
BG (1)	BG65504B1 (no)
BR (1)	BR0012335A (no)
CA (1)	CA2377909C (no)
CY (1)	CY1106206T1 (no)
CZ (1)	CZ300094B6 (no)
DE (3)	DE60039313D1 (no)
DK (3)	DK1523983T3 (no)
EA (1)	EA004294B1 (no)
EE (1)	EE04995B1 (no)
ES (3)	ES2235919T3 (no)
FR (1)	FR2795961B1 (no)
GE (1)	GEP20043287B (no)
HK (1)	HK1044894B (no)
HR (1)	HRP20020111B1 (no)
HU (1)	HU229044B1 (no)
IL (2)	IL147499A0 (no)
IS (1)	IS2157B (no)
ME (1)	ME01361B (no)
MX (1)	MXPA02000324A (no)
NO (1)	NO333301B1 (no)
NZ (1)	NZ516416A (no)
PL (1)	PL212082B1 (no)
PT (3)	PT1523983E (no)
RS (1)	RS50035B (no)
SI (2)	SI1574214T1 (no)
SK (1)	SK287484B6 (no)
TR (1)	TR200200008T2 (no)
UA (1)	UA72925C2 (no)
WO (1)	WO2001003693A1 (no)
ZA (1)	ZA200200169B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2795961B1 (fr) *	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) *	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US20080241070A1 (en) *	2000-09-21	2008-10-02	Elan Pharma International Ltd.	Fenofibrate dosage forms
FR2819720B1 (fr) *	2001-01-22	2004-03-12	Fournier Lab Sa	Nouveaux comprimes de fenofibrate
GB0119480D0 (en)	2001-08-09	2001-10-03	Jagotec Ag	Novel compositions
PT1551372T (pt) *	2002-09-20	2018-07-23	Alpharma Pharmaceuticals Llc	Subunidade de sequestração e composições e métodos relacionados
EP1553928A1 (en) *	2002-09-24	2005-07-20	Ranbaxy Laboratories, Ltd.	Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN100367947C (zh) *	2002-12-04	2008-02-13	徐州恩华赛德药业有限责任公司	具有抗高血脂症的含非诺贝特的药物组合物
EP1829541A1 (en) *	2002-12-17	2007-09-05	Abbott GmbH & Co. KG	Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
US20080051411A1 (en) *	2002-12-17	2008-02-28	Cink Russell D	Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
CN100473378C (zh) *	2002-12-17	2009-04-01	阿伯特有限及两合公司	包含非诺贝酸、其生理可接受的盐或衍生物的制剂
WO2005002541A2 (en) *	2003-07-02	2005-01-13	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US7264813B2 (en)	2003-09-24	2007-09-04	Nikken Sohonsha Corporation	Therapeutic uses of Dunaliella powder
US8062664B2 (en)	2003-11-12	2011-11-22	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) *	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate
WO2006089674A2 (en) *	2005-02-25	2006-08-31	F.Hoffmann-La Roche Ag	Tablets with improved drug substance dispersibility
WO2006107316A1 (en) *	2005-03-30	2006-10-12	Teva Pharmaceutical Industries Ltd.	Improved formulations of fenofibrate containing menthol or peg/poloxamer
US20080152714A1 (en) *	2005-04-08	2008-06-26	Yi Gao	Pharmaceutical Formulations
US20090210197A1 (en) *	2006-05-23	2009-08-20	Intelemetrix Ltd	Data accessing system and method
MX2008016372A (es)	2006-06-19	2009-05-28	Alpharma Inc	Composiciones farmaceuticas.
KR100767349B1 (ko) *	2006-08-01	2007-10-17	삼천당제약주식회사	페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (en) *	2006-09-27	2008-05-21	Novartis AG	Pharmaceutical compositions comprising nilotinib or its salt
AU2007322269A1 (en) *	2006-10-11	2008-05-29	Alpharma Pharmaceuticals, Llc	Pharmaceutical compositions
JP4993274B2 (ja) *	2006-12-05	2012-08-08	日医工株式会社	フェノフィブラート含有製剤組成物の製造方法
US8623418B2 (en)	2007-12-17	2014-01-07	Alpharma Pharmaceuticals Llc	Pharmaceutical composition
EP2224805A4 (en) *	2007-12-17	2013-10-16	Alpharma Pharmaceuticals Llc	PHARMACEUTICAL COMPOSITION
FR2940118B1 (fr) *	2008-12-24	2013-08-09	Ethypharm Sa	Formulation pharmaceutique de fenofibrate nanonise
JPWO2010092925A1 (ja) *	2009-02-12	2012-08-16	あすか製薬株式会社	固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) *	2009-03-06	2010-11-10	安徽省药物研究所	非诺贝特药物组合物
US20100291201A1 (en) *	2009-05-14	2010-11-18	Cerovene, Inc.	Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) *	2010-04-12	2012-11-21	한미사이언스 주식회사	페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) *	2011-09-07	2014-09-11	Ethypharm	Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) *	2012-05-29	2013-12-05	주식회사 브이터치	프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en)	2012-06-25	2014-05-13	Mylan, Inc.	Fenofibrate formulation
WO2014091318A1 (en)	2012-12-11	2014-06-19	Lupin Atlantis Holdings, S.A.	Reduced dose pharmaceutical compositions of fenofibrate
US20160289393A1 (en) *	2013-12-04	2016-10-06	Dow Global Technologies Llc	Process for prepring a mixture of a cellulose derivative and a liquid diluent
CN104352466A (zh) *	2014-11-17	2015-02-18	辰欣药业股份有限公司	一种非诺贝特组合物及其制剂
CN107961224B (zh) *	2017-12-06	2021-05-04	齐鲁制药(海南)有限公司	一种阿昔替尼片及其制备方法
KR102407512B1 (ko)	2019-10-30	2022-06-13	주식회사 대웅테라퓨틱스	피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) *	2020-09-25	2020-12-25	迪沙药业集团有限公司	一种非诺贝特片组合物及其制备方法
KR102489384B1 (ko) *	2020-09-29	2023-01-18	애드파마 주식회사	생체이용율이 개선된 페노피브레이트 입자를 포함하는 약제학적 조성물
CN112121023A (zh) *	2020-09-30	2020-12-25	迪沙药业集团有限公司	一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4058552A (en)	1969-01-31	1977-11-15	Orchimed Sa	Esters of p-carbonylphenoxy-isobutyric acids
CH543472A (fr)	1969-01-31	1973-10-31	Orchimed Sa	Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
GB1579818A (en)	1977-06-07	1980-11-26	Yamanouchi Pharma Co Ltd	Nifedipine-containing solid preparation composition
US4344934A (en)	1978-11-20	1982-08-17	American Home Products Corporation	Therapeutic compositions with enhanced bioavailability
DE2966564D1 (en)	1978-11-20	1984-02-23	American Home Prod	Therapeutic compositions with enhanced bioavailability and process for their preparation
FR2494112B1 (no)	1980-11-19	1986-01-10	Laruelle Claude
GB8414221D0 (en)	1984-06-04	1984-07-11	Sterwin Ag	Unit dosage form
GB8414220D0 (en)	1984-06-04	1984-07-11	Sterwin Ag	Medicaments in unit dose form
FR2602423B1 (fr)	1986-08-08	1989-05-05	Ethypharm Sa	Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en)	1986-11-24	1988-06-21	Mehta Atul M	Controlled release indomethacin
US4895725A (en) *	1987-08-24	1990-01-23	Clinical Technologies Associates, Inc.	Microencapsulation of fish oil
FR2627696B1 (fr)	1988-02-26	1991-09-13	Fournier Innovation Synergie	Nouvelle forme galenique du fenofibrate
DE59005781D1 (de)	1990-07-02	1994-06-23	Boehringer Mannheim Gmbh	Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit.
JP3125221B2 (ja) *	1990-09-01	2001-01-15	大正製薬株式会社	ソファルコン含有固形製剤
JP3037393B2 (ja) *	1990-10-22	2000-04-24	大正薬品工業株式会社	経口投与用固形薬剤の製造方法
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
US5223268A (en) *	1991-05-16	1993-06-29	Sterling Drug, Inc.	Low solubility drug-coated bead compositions
DE69127275T2 (de) *	1991-06-21	1998-03-12	Ilsan Ilac Ve Hammaddeleri San	Neues galenisches Verfahren für Omeprazol enthaltende Pellets
SE9402422D0 (sv)	1994-07-08	1994-07-08	Astra Ab	New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr)	1994-07-26	1996-10-18	Effik Lab	Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) *	1995-01-10	1996-08-13	Galephar P.R. Inc.	Pharmaceutical composition containing fenofibrate
US5558879A (en) *	1995-04-28	1996-09-24	Andrx Pharmaceuticals, Inc.	Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de)	1996-03-06	1997-09-11	Durachemie Gmbh & Co Kg	Verfahren zur Herstellung von Fenofibrat-Präparaten
SK177598A3 (en) *	1996-06-28	1999-07-12	Schering Corp	Oral composition comprising a triazole antifungal compound
FR2758461A1 (fr)	1997-01-17	1998-07-24	Pharma Pass	Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr)	1997-01-17	1999-05-07	Pharma Pass	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
AU2005299A (en) *	1997-12-20	1999-07-12	Genencor International, Inc.	Fluidized bed matrix granule
JP2000086509A (ja) *	1998-09-14	2000-03-28	Taisho Yakuhin Kogyo Kk	ソファルコン含有製剤の製造方法
FR2783421B1 (fr) *	1998-09-17	2000-11-24	Cll Pharma	Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) *	1999-06-11	2002-04-09	Abbott Laboratories	Formulations comprising lipid-regulating agents
US7863331B2 (en) *	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr)	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US6667064B2 (en)	2000-08-30	2003-12-23	Pilot Therapeutics, Inc.	Composition and method for treatment of hypertriglyceridemia
EP1322289B1 (en) *	2000-09-20	2007-07-25	Jagotec AG	Spray drying process of compositions containing fenofibrate
US8026281B2 (en)	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate

1999
- 1999-07-09 FR FR9908923A patent/FR2795961B1/fr not_active Expired - Lifetime
2000
- 2000-07-07 PL PL352307A patent/PL212082B1/pl unknown
- 2000-07-07 EP EP04027226A patent/EP1523983B1/fr not_active Expired - Lifetime
- 2000-07-07 DE DE60039313T patent/DE60039313D1/de not_active Expired - Lifetime
- 2000-07-07 EE EEP200200011A patent/EE04995B1/xx unknown
- 2000-07-07 MX MXPA02000324A patent/MXPA02000324A/es active IP Right Grant
- 2000-07-07 PT PT04027226T patent/PT1523983E/pt unknown
- 2000-07-07 ES ES00949677T patent/ES2235919T3/es not_active Expired - Lifetime
- 2000-07-07 ES ES05006751T patent/ES2271924T3/es not_active Expired - Lifetime
- 2000-07-07 CA CA2377909A patent/CA2377909C/fr not_active Expired - Lifetime
- 2000-07-07 SI SI200030894T patent/SI1574214T1/sl unknown
- 2000-07-07 HU HU0202338A patent/HU229044B1/hu not_active IP Right Cessation
- 2000-07-07 AT AT00949677T patent/ATE291912T1/de active
- 2000-07-07 HK HK02106433.0A patent/HK1044894B/zh not_active IP Right Cessation
- 2000-07-07 HR HR20020111A patent/HRP20020111B1/xx not_active IP Right Cessation
- 2000-07-07 PT PT00949677T patent/PT1194140E/pt unknown
- 2000-07-07 WO PCT/FR2000/001971 patent/WO2001003693A1/fr not_active Ceased
- 2000-07-07 IL IL14749900A patent/IL147499A0/xx active IP Right Grant
- 2000-07-07 AT AT05006751T patent/ATE341320T1/de active
- 2000-07-07 DK DK04027226T patent/DK1523983T3/da active
- 2000-07-07 SI SI200030633T patent/SI1194140T1/xx unknown
- 2000-07-07 DE DE60031184T patent/DE60031184T2/de not_active Expired - Lifetime
- 2000-07-07 CZ CZ20020002A patent/CZ300094B6/cs not_active IP Right Cessation
- 2000-07-07 JP JP2001508973A patent/JP4841092B2/ja not_active Expired - Lifetime
- 2000-07-07 CN CNB008101469A patent/CN1204885C/zh not_active Expired - Lifetime
- 2000-07-07 SK SK15-2002A patent/SK287484B6/sk not_active IP Right Cessation
- 2000-07-07 BR BR0012335-8A patent/BR0012335A/pt not_active Application Discontinuation
- 2000-07-07 UA UA2002021052A patent/UA72925C2/uk unknown
- 2000-07-07 KR KR1020027000329A patent/KR20020025188A/ko not_active Ceased
- 2000-07-07 DE DE60019120T patent/DE60019120T2/de not_active Expired - Lifetime
- 2000-07-07 NZ NZ516416A patent/NZ516416A/en not_active IP Right Cessation
- 2000-07-07 EP EP00949677A patent/EP1194140B1/fr not_active Expired - Lifetime
- 2000-07-07 CN CN2005100648532A patent/CN1682707B/zh not_active Expired - Lifetime
- 2000-07-07 TR TR2002/00008T patent/TR200200008T2/xx unknown
- 2000-07-07 DK DK05006751T patent/DK1574214T3/da active
- 2000-07-07 DK DK00949677T patent/DK1194140T3/da active
- 2000-07-07 EP EP05006751A patent/EP1574214B1/fr not_active Expired - Lifetime
- 2000-07-07 RS YUP-932/01A patent/RS50035B/sr unknown
- 2000-07-07 US US10/030,262 patent/US7101574B1/en not_active Expired - Lifetime
- 2000-07-07 AT AT04027226T patent/ATE399006T1/de active
- 2000-07-07 PT PT05006751T patent/PT1574214E/pt unknown
- 2000-07-07 ME MEP-2001-932A patent/ME01361B/me unknown
- 2000-07-07 GE GEAP20006316A patent/GEP20043287B/en unknown
- 2000-07-07 AU AU62960/00A patent/AU782282B2/en not_active Expired
- 2000-07-07 ES ES04027226T patent/ES2309438T3/es not_active Expired - Lifetime
- 2000-07-07 EA EA200200147A patent/EA004294B1/ru not_active IP Right Cessation
2002
- 2002-01-02 NO NO20020014A patent/NO333301B1/no not_active IP Right Cessation
- 2002-01-03 IS IS6218A patent/IS2157B/is unknown
- 2002-01-04 BG BG106280A patent/BG65504B1/bg unknown
- 2002-01-07 IL IL147499A patent/IL147499A/en unknown
- 2002-01-09 ZA ZA200200169A patent/ZA200200169B/en unknown
2006
- 2006-05-29 KR KR1020060048212A patent/KR20060073549A/ko not_active Ceased
- 2006-08-25 US US11/509,806 patent/US8658212B2/en not_active Expired - Lifetime
- 2006-10-18 CY CY20061101495T patent/CY1106206T1/el unknown
2007
- 2007-02-02 KR KR1020070010902A patent/KR100766644B1/ko not_active Expired - Lifetime
2008
- 2008-06-11 US US12/155,937 patent/US20080248101A1/en not_active Abandoned
2010
- 2010-06-25 US US12/823,900 patent/US8563042B2/en not_active Expired - Fee Related
2011
- 2011-03-15 JP JP2011057117A patent/JP2011148813A/ja active Pending

Also Published As

Publication number	Publication date
DE60039313D1 (de)	2008-08-07
EP1523983A1 (fr)	2005-04-20
US8563042B2 (en)	2013-10-22
SK287484B6 (sk)	2010-11-08
KR100766644B1 (ko)	2007-10-15
RS50035B (sr)	2008-11-28
HK1080391A1 (en)	2006-04-28
CA2377909A1 (fr)	2001-01-18
IS2157B (is)	2006-11-15
EP1523983B1 (fr)	2008-06-25
IL147499A0 (en)	2002-08-14
ES2309438T3 (es)	2008-12-16
DE60031184T2 (de)	2007-08-23
JP2003504331A (ja)	2003-02-04
PT1523983E (pt)	2008-09-19
NZ516416A (en)	2003-10-31
SI1194140T1 (en)	2005-06-30
BG65504B1 (bg)	2008-10-31
EA200200147A1 (ru)	2002-06-27
US8658212B2 (en)	2014-02-25
ME01361B (me)	2008-11-28
HK1074588A1 (zh)	2005-11-18
TR200200008T2 (tr)	2002-06-21
EE200200011A (et)	2003-02-17
DK1194140T3 (da)	2005-07-04
US20110159082A1 (en)	2011-06-30
JP2011148813A (ja)	2011-08-04
NO333301B1 (no)	2013-04-29
HK1044894A1 (en)	2002-11-08
EP1574214A1 (fr)	2005-09-14
BG106280A (en)	2002-08-30
IS6218A (is)	2002-01-03
WO2001003693A1 (fr)	2001-01-18
CY1106206T1 (el)	2011-06-08
EA004294B1 (ru)	2004-02-26
US7101574B1 (en)	2006-09-05
HU229044B1 (hu)	2013-07-29
US20080248101A1 (en)	2008-10-09
HUP0202338A2 (en)	2002-10-28
PL352307A1 (en)	2003-08-11
EP1574214B1 (fr)	2006-10-04
FR2795961A1 (fr)	2001-01-12
DE60019120T2 (de)	2006-02-09
SI1574214T1 (sl)	2006-12-31
EP1194140B1 (fr)	2005-03-30
ES2271924T3 (es)	2007-04-16
FR2795961B1 (fr)	2004-05-28
CZ20022A3 (cs)	2002-05-15
DK1574214T3 (da)	2007-01-22
HK1044894B (zh)	2005-06-24
BR0012335A (pt)	2002-03-19
CZ300094B6 (cs)	2009-01-28
PT1574214E (pt)	2007-01-31
DE60019120D1 (de)	2005-05-04
ZA200200169B (en)	2002-07-31
PT1194140E (pt)	2005-07-29
SK152002A3 (en)	2002-07-02
AU782282B2 (en)	2005-07-14
KR20060073549A (ko)	2006-06-28
ATE399006T1 (de)	2008-07-15
NO20020014D0 (no)	2002-01-02
YU93201A (sh)	2004-09-03
KR20020025188A (ko)	2002-04-03
HRP20020111A2 (en)	2003-04-30
IL147499A (en)	2007-03-08
KR20070026716A (ko)	2007-03-08
EP1194140A1 (fr)	2002-04-10
CN1682707A (zh)	2005-10-19
PL212082B1 (pl)	2012-08-31
CN1682707B (zh)	2010-05-05
DE60031184D1 (de)	2006-11-16
EE04995B1 (et)	2008-04-15
GEP20043287B (en)	2004-07-26
HRP20020111B1 (en)	2005-12-31
ES2235919T3 (es)	2005-07-16
CN1360499A (zh)	2002-07-24
AU6296000A (en)	2001-01-30
CA2377909C (fr)	2011-06-28
US20070071812A1 (en)	2007-03-29
ATE291912T1 (de)	2005-04-15
MXPA02000324A (es)	2002-06-21
UA72925C2 (uk)	2005-05-16
JP4841092B2 (ja)	2011-12-21
HUP0202338A3 (en)	2003-03-28
DK1523983T3 (da)	2008-10-13
CN1204885C (zh)	2005-06-08
ATE341320T1 (de)	2006-10-15

Publication	Publication Date	Title
NO20020014L (no)	2002-03-04	Farmasöytisk sammensetning som inneholder fenofibrat og fremgangsmåte til fremstilling derav
IT1313618B1 (it)	2002-09-09	Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici eprocedimento per la loro preparazione.
NO20011721D0 (no)	2001-04-05	N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
DE60204452D1 (de)	2005-07-07	Pyrazolo[1,5]pyridinderivate
BR0012250A (pt)	2002-03-26	Processo de fabricação de grânulos revestidos com gosto mascarado, e liberação imediata do princìpio ativo, grânulo revestido, comprimido multiparticulado de dissolução rápida e comprimido de hidrodispersibilidade rápida
NO993519L (no)	1999-09-16	Fenofibrat farmasöytisk blanding som har höy biotilgjengelighet og fremgangsmÕte for fremstilling av den
CA2416867A1 (en)	2002-01-31	Cyclopentanoindoles, compositions containing such compounds and methods of treatment
ES2060784T3 (es)	1994-12-01	Granulos que tienen un nucleo y su produccion.
BR0009410A (pt)	2002-02-13	Piridina-2,3-dicarboxamida, composto, uso de uma piridina-2,3-dicarboxamida, composição herbicida, composição para a dessecação e/ou desfolhação de vegetais, e, processo para controlar vegetação não desejável
ATE534656T1 (de)	2011-12-15	Neue oligosaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
MX9700564A (es)	1997-05-31	Derivados de benzoilo y sintesis de los mismos.
ATE284853T1 (de)	2005-01-15	Ureido-thiobuttersäurederivate als ppar-agonisten
EA199700093A1 (ru)	1998-02-26	ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК
HUP9802995A3 (en)	1999-04-28	Substituted sulphonylamino (thio)carbonyl derivatives, intermediates, thereof herbicide compositions containing these compounds as active ingredients, process for the preparation and use of the compounds and compositions
ATE426006T1 (de)	2009-04-15	Pigmentpraparation
YU72802A (sh)	2006-01-16	Farmaceutske smeše koje sadrže oligosaharide, novi oligosaharidi i njihovo dobijanje
KR940006583A (ko)	1994-04-25	약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질
IS4052A (is)	1994-02-11	Aðferð til framleiðslu á 3- og 5- greinóttar (substituted) 1, 2, 3, 4-oxatriazole-5- imine efnasamböndum
AU2002366724A1 (en)	2003-07-09	Stable granulates containing s-adenosylmethionne and process for the preparation thereof
CA2355720A1 (en)	2000-08-24	New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
BR0307172A (pt)	2004-11-03	Composição farmacêutica contendo 2,2-dicloro-12-(4-clorofenil)-ácido dodecanóico
ITRM930546A0 (it)	1993-08-09	Nuovi derivati imidazolici, procedimento per la loro preparazione e loro applicazione come pesticidi.
WO2000046193A3 (en)	2000-12-21	Ether derivatives having neuronal activity

Legal Events

Date	Code	Title	Description
2020-02-24	MM1K	Lapsed by not paying the annual fees